Simnova

Simnova (Shanghai Simnova Biotechnology Co., Ltd.) is dedicated to bringing innovative cell therapy products to cancer patients. Simnova has a robust R&D pipeline, including both clinical and preclinical projects, with technological strengths in its self-developed off-the-shelf CAR-NK and BiTE CAR-T technology platforms. Simnova has R&D teams in both Shanghai and Boston and is a sister company of the publicly listed Simcere Pharmaceutical Group (2096.HK).